High levels of GDNF are associated with neuroprotection, recovery from trauma or severe stress, and the prevention of degenerative cognitive decline
The prescription peptides semaglutide, liraglutide, and tirzepatide are generally intended for people with a body mass index (BMI) of 30 or higher , or a BMI of 27 or higher with weight-related health conditions such as type 2 diabetes, high blood pressure, or sleep apnea (FDA Wegovy prescribing information)
Community sources note that this creates a procurement barrier for research-context use, which is one reason the peptide-vendor channel and compounding pharmacy alternatives exist
Supporting muscle and nerve function: Beyond tendons and ligaments, research suggests that BPC-157 may stabilize the junctions between nerves and muscles, preserve acetylcholine receptors (the chemical messengers at nerve-muscle connections), and enhance muscle regeneration while reducing scar tissue formation
In extreme circumstances, dementia
The FDAs April 22 change does not materially expand what a pharmacist can lawfully compound